ATXS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 138124 min ago

@ $14.28

Wydano: 14 vas. 2024 @ 19:06

Zwrot: -34.45%

Poprzedni sygnał: vas. 13 - 21:46

Poprzedni sygnał: Sprzedaż

Zwrot: -0.35 %

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 17:59):

Stats
Dzisiejszy wolumen	43 508.00
Średni wolumen	1.02M
Kapitalizacja rynkowa	513.99M
EPS	$0 ( 2024-05-09 )
Następna data zysków	( $-0.360 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.90
ATR14	$0.0300 (0.32%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Agarwal Sunil	Buy	28 200	Stock Option (Right to Buy)
2024-04-05	Agarwal Sunil	Buy	0
2024-04-01	Morabito Christopher	Sell	10 000	Stock Option (Right to Buy)
2024-04-01	Morabito Christopher	Buy	10 000	Common Stock
2024-04-01	Morabito Christopher	Sell	10 000	Common Stock

INSIDER POWER
96.97
Last 97 transactions
Buy: 15 860 733 \| Sell: 474 752

Wolumen Korelacja

Długi: 0.27 (neutral)

Krótki: -0.85 (strong negative)

Signal:(43.094) Neutral

Astria Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Astria Therapeutics, Inc. Korelacja - Waluta/Towar

0.40
( neutral )

0.33
( neutral )

0.00
( neutral )

0.32
( neutral )

-0.79
( moderate negative )

-0.48
( neutral )

Astria Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-2.42

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-2.42

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-3.43

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-49.16

Financial Reports:

No articles found.

Astria Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.